Talkspace, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Bobby Brooks from Northland Securities maintained a Buy rating on the stock and has a $5.50 price target.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bobby Brooks has given his Buy rating due to a combination of factors that point to strong, underappreciated growth prospects for Talkspace. He highlights that Talkspace operates in a large and growing mental health market, supported by extensive insurance coverage and recent product improvements that make it easier for patients to enroll and remain engaged. Brooks notes that utilization is already inflecting higher, with record new sign-ups and rising average sessions per insured member, and he views these trends as early evidence of a much longer growth trajectory that the current share price does not yet capture.
Brooks also emphasizes the impact of deeper integration with health insurance portals, which has already transformed one payor group into Talkspace’s largest cohort by sharply reducing friction in the booking process. With three additional portal integrations planned, he expects this utilization boost to replicate across a larger covered population. Finally, he points to the upcoming launch of Talkspace’s HIPAA-compliant, clinician-reviewed LLM—built on years of proprietary clinical data—as a meaningful incremental revenue opportunity that is not yet reflected in his financial model, reinforcing his conviction in the Buy rating.
Brooks covers the Industrials sector, focusing on stocks such as Graham, Tetra Technologies, and Ceco Environmental. According to TipRanks, Brooks has an average return of 44.7% and a 72.87% success rate on recommended stocks.
In another report released on December 29, Canaccord Genuity also reiterated a Buy rating on the stock with a $6.00 price target.